Overview

Multi-Center Study of New Medications to Treat Vaginal Infections

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of terconazole/metronidazole gel in the treatment of vaginal infections
Phase:
Phase 3
Details
Lead Sponsor:
Curatek Pharmaceuticals, LLC
Treatments:
Metronidazole
Terconazole